- Home
- KG vs ECOR Comparison
KG vs ECOR Comparison
Compare KG & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KG | ECOR |
|---|---|---|
| Founded | N/A | 2005 |
| Country | Bermuda | United States |
| Employees | 44 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.3M | 81.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | KG | ECOR |
|---|---|---|
| Price | $8.60 | $6.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 13.8K | ★ 70.3K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $1.38 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $8.07 | $4.16 |
| 52 Week High | $31.45 | $10.50 |
Technical Indicators
Market Signals| Indicator | KG | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 32.66 | 38.51 |
| Support Level | $8.15 | $5.69 |
| Resistance Level | $12.02 | $7.35 |
| Average True Range (ATR) | 0.51 | 0.55 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 0.00 | 30.99 |
Price Performance
Historical ComparisonAbout KG Kestrel Group Ltd.
Kestrel Group Ltd specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers with two reportable segments: Program Services and Legacy Reinsurance. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.